Facebook Live: The Prescription Drug Pricing Pipeline

http://khn.org/news/facebook-live-the-prescription-drug-pricing-pipeline/?utm_campaign=KHN%3A%20First%20Edition&utm_source=hs_email&utm_medium=email&utm_content=55788948&_hsenc=p2ANqtz–od0NkOnZ3JW63AcEvWasisokdBxSkvpXO26Fjun675RM0hdMqrzrJFyv1mPagID4A6YaGGliyY42elFVZt4M1Cbax7A&_hsmi=55788948

Related image

 

Who contributes to what you pay at the pharmacy? Why are prescription drugs so expensive in the United States? In this Facebook Live, KHN’s Julie Appleby talks with Stephanie Stapleton and answers readers’ questions about the prescription drug pricing pipeline and the industry stakeholders who have a role in what you pay.

For more in-depth conversations with KHN reporters, check out our Facebook video archive.

Here are videos and a chart to help make sense of drug pricing. And remember you can republish KHN content for free:

Pharmacy benefit managers — companies that are often unnoticed and even less understood by most consumers — hold an important place in the prescription drug-pricing pipeline. In this video, Kaiser Health News details the emergence of these multimillion-dollar corporations and the impact they have on medication costs and patients’ access to these treatments.

Healthcare Triage: Orphan Drugs part 4 – Fixing the System

Healthcare Triage: Orphan Drugs part 4 – Fixing the System

Image result for Healthcare Triage: Orphan Drugs part 4 – Fixing the System

Drug companies love the Orphan Drug Act. They say it encourages research into breakthrough therapies for people with rare disease. And sometimes that’s true. Lots of the time, though, the companies would’ve pursued the research anyhow. And those same companies have learned to game the Orphan Drug Act in a bunch of different ways, allowing them to jack up their prices for no good reason.

How could we fix the Orphan Drug Act? That’s the topic of this week’s Healthcare Triage.

 

Healthcare Triage: Gaming the System – Orphan Drugs Part 3

Healthcare Triage: Gaming the System – Orphan Drugs Part 3

Image result for Healthcare Triage: Gaming the System – Orphan Drugs Part 3

Even if the Orphan Drug Act were working properly, its enormous costs might outweigh its exiguous benefits. But it’s not working properly. Drug manufacturers are gaming the Act in at least three important ways. They’re the topic of this week’s Healthcare Triage.

Three drug trends impacting specialty pharmacy

http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/three-drug-trends-impacting-specialty-pharmacy?cfcache=true

Specialty Drugs

Prescription drug spending surges amid market forces

http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/prescription-drug-spending-surges-amid-market-forces?cfcache=true